The specific features of T cell immunity in breast cancer

Por L. V. Skotarenko, I. K. Vorotnikov, Z. G. Kadagidze, F. A. Shamilov
Publicado em 2014-08-01

ANDROGEN RECEPTORS AS A FACTOR OF PROGNOSIS IN VARIOUS MOLECULAR-BIOLOGICAL SUBTYPES OF BREAST CANCER

Por D. A. Ryabchikov, I. K. Vorotnikov, N. A. Kozlov, N. V. Chkhikvadze
Publicado em 2017-07-01

Immunological and molecular genetic characteristics of luminal B breast cancer: a literature review

Por D. A. Ryabchikov, I. K. Vorotnikov, K. S. Titov, N. V. Chkhikvadze, A. V. Krasnorutskiy
Publicado em 2017-02-01

Specific features of Brodie’s tumors

Por D. A. Denchik, I. K. Vorotnikov, L. N. Lyubchenko, O. A. Anurova, A. V. Bykova
Publicado em 2014-08-01

Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer

Por A. V. Bykova, I. K. Vorotnikov, Ya. V. Vishnevskaya, D. A. Denchik, L. N. Lyubchenko
Publicado em 2014-07-01

ACTUAL ISSUES OF ONCOPLASTIC ORGAN-PRESERVING SURGERY OF BREAST CANCER

Por D. A. Ryabchicov, I. K. Vorotnikov, I. A. Dudina, A. M. Kazakov, D. A. Denchik
Publicado em 2019-12-01

Lymphocyte subpopulations of bone marrow of breast cancer patients

Por T. A. Grigorieva, O. A. Beznos, N. N. Tupitsyn, I. K. Vorotnikov, V. Yu. Selchuk, D. A. Ryabchikov
Publicado em 2015-07-01

Breast sarcomas. Literature review

Por D. A. Ryabchikov, I. K. Vorotnikov, N. V. Chkhikvadze, Ye. Ye. Mironova, M. V. Rodionova, V. A. Mkrtchyan
Publicado em 2014-07-01

SURGICAL TREATMENT OF BREAST CANCER: FROM THE CONCEPT OF ERADICATION TO AESTHETIC SURGERY

Por I. K. Vorotnikov, V. P. Letyagin, I. V. Vysotskaya, V. Yu. Sel’chuk, D. A. Burov, A. V. Pavlov
Publicado em 2018-08-01

Oral contraceptives and menopausal hormone therapy as breast cancer risk categories

Por I. V. Vуsotskaya, V. P. Letyagin, I. K. Vorotnikov, V. U. Kirsanov, I. A. Gladilina, E. A. Kim
Publicado em 2019-09-01

Interrelation of tumor infiltrating lymphocyte subpopulations with clinical and pathomorphological features of a breast cancer

Por O. A. Beznos, D. A. Burov, V. Yu. Sel’chuk, I. K. Vorotnikov, V. V. Timoshenko, T. A. Grigor’eva, Ya. V. Vishnevskaya, N. N. Tupitsyn
Publicado em 2016-09-01

Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery

Por L. N. Lyubchenko, Ye. I. Bateneva, I. K. Vorotnikov, S. M. Portnoy, O. V. Krokhina, V. A. Sobolevskiy, L. G. Zhukova, V. A. Khaylenko, S. A. Tyulyandin
Publicado em 2015-06-01

PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF KI67 DYNAMIC CHANGE DURING PREOPERATIVE ENDOCRINE THERAPY IN BREAST CNACER PATIENTS

Por M. V. Rodionova, I. K. Vorotnikov, V. V. Rodionov, E. A. Dudko, N. V. Chkhivadze, V. V. Kometova, D. A. Ryabchikov, E. V. Oshkina, A. S. Ozherelyev, T. А. Bogush
Publicado em 2016-02-01

RESULTS OF EARLY-STAGE BREAST CANCER PATIENTS’ TREATMENT USING ACCELERATED PARTIAL BREAST IRRADIATION TECHNIQUE AFTER BREAST-CONSERVING SURGERY. EXPERIENCE OF N.N. BLOKHIN NATIONAL...

Por O. P. Trofimova, N. V. Volkova, A. V. Nazarenko, I. V. Kolyadina, V. A. Haylenko, S. I. Tkachev, J. I. Pryamikova, E. V. Timoshkina, O. S. Zaychenko, V. A. Boldyreva, I. K. Vorotnikov, S. B. Alieva, T. N. Borisova, V. V. Glebovskaya, S. M. Ivanov
Publicado em 2017-12-01

EXPERIENCE WITH SUBCUTANEOUS TRASTUZUMAB USED IN RUSSIAN FEDERATION

Por E. V. Lubennikova, I. P. Ganshina, A. N. Lud, D. V. Komov, I. V. Kolyadina, Y. V. Vishnevskaya, I. K. Vorotnikov, D. L. Stroyakovsky, N. A. Savelov, V. F. Semiglazov, А. G. Manikhas, А. V. Osheychik, T. B. Strelnikova, K. R. Zeynalova, L. G. Zhukova
Publicado em 2017-11-01